Initial Antihypertensive Therapy for African Americans with Hypertension

First-Line Therapy Recommendations

• The American College of Cardiology recommends that initial antihypertensive treatment for black adults with hypertension should include a thiazide-type diuretic or calcium channel blocker (CCB), as they are more effective in lowering blood pressure in African Americans than renin-angiotensin system (RAS) inhibitors or beta blockers 1, 2, 3
• Thiazide-type diuretics or CCBs are more effective in reducing cardiovascular disease events than RAS inhibitors or alpha blockers in African Americans 1, 4
• The American College of Cardiology suggests that for optimal endpoint protection, chlorthalidone should be administered at a dose of 12.5 to 25 mg/day (or hydrochlorothiazide 25-50 mg/day) 1
• The CCB amlodipine is as effective as chlorthalidone and more effective than lisinopril in reducing BP, CVD, and stroke events in African Americans, though less effective in preventing heart failure 1

Combination Therapy Considerations

• The American College of Cardiology recommends that two or more antihypertensive medications are recommended to achieve a BP target of less than 130/80 mm Hg in most adults with hypertension, especially in black adults 1, 2
• A single-tablet combination that includes either a diuretic or a CCB may be particularly effective in achieving BP control in African Americans 5
• The International Society of Hypertension guidelines recommend for black patients initial therapy with low dose ARB + dihydropyridine CCB or dihydropyridine CCB + thiazide-like diuretic, then increase to full dose, followed by adding a diuretic or ACE/ARB if not already included 6

Special Clinical Scenarios

• For African Americans with chronic kidney disease and proteinuria, ACE inhibitors or ARBs are recommended as components of multidrug antihypertensive regimens 1, 5
• For those with heart failure, beta blockers should be added to the regimen 1, 5
• For patients with coronary heart disease who have had a myocardial infarction, beta blockers are recommended 1
• African Americans have a greater risk of angioedema with ACE inhibitors, which should be considered when selecting therapy 1, 5

Practical Considerations

• Most African American patients with hypertension will require combination antihypertensive therapy to maintain BP consistently below target levels 1, 5
• Lifestyle modifications (weight reduction, dietary modification, increased physical activity, sodium restriction) are particularly important in African Americans but may be challenging due to socioeconomic factors 1, 3

Treatment Algorithm for African Americans with Hypertension

• Initial therapy: Thiazide-type diuretic or CCB as monotherapy if BP is <15/10 mmHg above goal, as recommended by the American College of Cardiology and the International Society of Hypertension 1, 6
• If BP is >15/10 mmHg above goal: Start with combination therapy of a CCB plus a thiazide diuretic, or a CCB plus an ARB, as recommended by the International Society of Hypertension 6
• If BP remains uncontrolled: Progress to triple therapy with CCB + thiazide diuretic + ARB/ACE inhibitor, as recommended by the American College of Cardiology and the International Society of Hypertension 5, 6
• For resistant hypertension: Add spironolactone or, if not tolerated, other agents such as eplerenone, amiloride, doxazosin, or a beta-blocker, as recommended by the International Society of Hypertension and the European Heart Journal 6, 7

Antihypertensive Treatment for African American Patients

Initial Therapy Recommendations

• Chlorthalidone has more cardiovascular disease risk reduction data than hydrochlorothiazide and has a longer therapeutic half-life, making it the preferred thiazide diuretic 8

Special Clinical Scenarios

• No cited facts are available for this section

Important Considerations and Cautions

• No cited facts are available for this section

First‑Line Antihypertensive Therapy in Obese African‑American Adults

Guideline Recommendations for First‑Line Agents

• The American College of Cardiology/American Heart Association (ACC/AHA) 2017 hypertension guideline recommends calcium‑channel blockers (CCBs) or thiazide‑type diuretics as the preferred first‑line agents for African‑American patients because they produce greater blood‑pressure reductions and lower cardiovascular‑event rates than renin‑angiotensin system inhibitors or beta‑blockers. 9

Metabolic Considerations of Thiazide Diuretics vs. Calcium‑Channel Blockers

• Thiazide diuretics cause dose‑related dyslipidemia and insulin resistance, which can aggravate metabolic‑syndrome components in obese individuals; in contrast, amlodipine (a CCB) is weight‑neutral and does not worsen lipid or glucose profiles. 10

Need for Combination Therapy

• Approximately 50–60 % of African‑American patients will fail to achieve a blood‑pressure target of <130/80 mmHg with monotherapy, indicating that early addition of a second agent is usually required. 9
• When combination therapy is indicated, adding an angiotensin‑II receptor blocker (ARB) to a CCB is preferred over adding a thiazide diuretic in patients with obesity and hyperlipidemia, because it avoids the metabolic adverse effects associated with thiazides. 9
• If the presenting blood pressure exceeds the goal by >15 mmHg systolic or >10 mmHg diastolic, guidelines advise starting combination therapy immediately rather than a step‑wise monotherapy approach. 11

Agents to Avoid in Obese African‑American Patients

Beta‑Blockers

• Beta‑blockers should not be used as first‑line therapy in obese patients because they lower metabolic rate and are linked to weight gain; they are reserved for patients with documented myocardial infarction or heart failure, and when needed, selective vasodilating agents (e.g., carvedilol, nebivolol) are preferred. [10][9]

ACE Inhibitors / ARBs (as Monotherapy)

• ACE inhibitors and ARBs are significantly less effective as monotherapy for blood‑pressure control in African‑American adults compared with CCBs or thiazides, and they provide no additional benefit over these agents in African‑American patients with diabetes without nephropathy. 9

Alpha‑Blockers

• Alpha‑adrenergic blockers are not recommended as first‑line agents because the ALLHAT trial showed an increased risk of heart‑failure hospitalization and notable weight gain with doxazosin. 10

Role of Beta‑Blockers and ACE/ARB in Specific Clinical Scenarios

• Beta‑blockers may be added only in African‑American patients who have a documented myocardial infarction or heart failure, reflecting a targeted rather than routine use. [9][11]

All statements are derived from peer‑reviewed sources cited above and reflect current ACC/AHA guideline recommendations.

First‑Line Antihypertensive Therapy for Black Adults with Hypertension

Thiazide‑type Diuretics (Preferred First‑Line Agent)

• Chlorthalidone 12.5–25 mg once daily provides superior cardiovascular risk reduction, maintains 24‑hour blood‑pressure control because of its long half‑life, and more effectively prevents heart‑failure events than other thiazide‑type diuretics in Black patients 12.

• In Black patients, thiazide diuretics achieve greater blood‑pressure lowering and reduce stroke and major cardiovascular events more effectively than ACE inhibitors or ARBs [13][14]12.

Calcium‑Channel Blockers (Acceptable Alternative)

• Amlodipine 5–10 mg daily lowers blood pressure to a similar extent as chlorthalidone and offers comparable protection against stroke and cardiovascular disease in Black patients [13][14].

• Compared with thiazides, amlodipine does not provoke metabolic adverse effects such as dyslipidaemia, insulin resistance, or hyperglycaemia [13][14].

• However, amlodipine is less effective than chlorthalidone for preventing heart failure, showing a ≈ 38 % higher incidence of heart‑failure events in head‑to‑head trials [13][14].

ACE Inhibitors and ARBs (Not Recommended as Initial Monotherapy)

• ACE inhibitors and ARBs produce significantly smaller reductions in blood pressure and provide less protection against stroke and heart‑failure in Black patients compared with thiazides or calcium‑channel blockers [13][14]12.

• Black patients have a higher incidence of ACE‑inhibitor‑induced angio‑edema than other racial groups 12.

• These agents should be reserved for compelling indications (e.g., diabetes with nephropathy, chronic kidney disease, established heart failure) or added later as part of combination therapy 12.

Anticipated Need for Combination Therapy

• The majority of Black patients require ≥ 2 antihypertensive agents to achieve the target blood‑pressure goal of < 130/80 mmHg [12][15].

• Combining a thiazide diuretic with a calcium‑channel blocker yields blood‑pressure reductions in Black patients that are comparable to those observed in other racial groups 12.

• Fixed‑dose single‑tablet combinations of a thiazide plus a calcium‑channel blocker improve medication adherence and are especially effective in this population 12.

Pitfalls to Avoid

• Do not initiate therapy with an ACE inhibitor or ARB as monotherapy in Black patients without a compelling indication, because of inferior efficacy for blood‑pressure control and cardiovascular protection 12.

• Do not prescribe hydrochlorothiazide at doses < 25 mg daily; lower doses have not demonstrated outcome benefit 15.

• Do not combine an ACE inhibitor with an ARB; this combination offers no additional benefit and is not recommended 15.

• Do not delay adding a second antihypertensive agent if blood pressure remains ≥ 130/80 mmHg after 4 weeks of adequate‑dose monotherapy, as most Black patients will need combination therapy [12][15].

• Do not use beta‑blockers as first‑line therapy unless there is a compelling indication (e.g., prior myocardial infarction or heart failure), because they are less effective for stroke prevention and may cause metabolic adverse effects [13][14].

Lifestyle Modifications (Adjunctive Therapy)

• Initiate comprehensive lifestyle changes immediately: sodium restriction to < 2.3 g/day, increased dietary potassium, weight management for overweight individuals, regular aerobic exercise, and limited alcohol intake 12.

• These non‑pharmacologic measures are particularly effective in Black patients and provide additive benefits to antihypertensive medications 12.